4 April 2022, Ostoform has announced the appointment of Stephan Bonnelycke as a non-executive Director of the company. Stephan is a hugely experienced MedTech professional and private equity advisor with particular experience in the ostomy sector. He was previously President and COO, Ostomy Care with Convatec where the annual turnover attributable to ostomy care was …
International MedTech veteran joins Ostoform board Read More »
Ostoform is pleased to announce that capital investor, BGF, has led a €3 million equity investment round in Ostoform. In addition to the investment from BGF, this equity round has been supported by Enterprise Ireland and existing investors including HBAN MedTech. In April of this year, Ostoform was awarded a grant of €2.7 million via …
Ostoform is pleased to announce its first-time attendance at Medica 2021. MEDICA, the world’s largest medical trade fair, will open to visitors from 15th – 18th November 2021. There are several thousand exhibitors from more than 65 nations registered to attend. This year it will be held as a hybrid event, with a physical trade …
Ostoform and consortium partners, Athlone Institute of Technology, Ross Polymers (Athlone), Synecco (Galway) and Avery Dennison (Longford) are very grateful to have received funding of €2.67 million through the Disruptive Technologies Innovation Fund, managed by Department of Enterprise, Trade and Employment and Enterprise Ireland. This award will support the development of a completely unique material …
At Ostoform, we are a small team of people working towards the common goal of solving problems experienced by those living with an ostomy. We are, therefore, proud to announce that we have partnered with US-based Medline Industries, Inc. for the commercialisation of a range of ostomy barrier rings, and the distribution of the Ostoform product …
Ostoform Announces U.S. Distribution Agreement with Medline Industries Read More »
Ostoform Limited today announce that Advances in Skin & Wound Care has published results of a third clinical study which evaluates the Ostoform Seal with FLOWASSIST Protection for individuals with an ileostomy. In the trial of 20 participants, 35% experienced an improvement in skin condition, 55% experienced no change in skin condition and 10% experienced …
Ostoform Clinical Study Published in Advances in Skin & Wound Care Read More »
Ostoform is delighted to announce that a second clinical study using the Ostoform Seal with FLOWASSIST Protection has been published in the prominent Wound Management and Prevention Journal. This was a pilot study, which demonstrated encouraging results and positive user feedback. To read the Abstract, click here To read the full Article, click here
Ostoform is delighted to announce that it has closed a funding round of €1.1m. Investors include HBAN MedTech Angel Investment Syndicate, SOS Ventures and some experienced Medtech entrepreneurs. The funds will enable the company to finalise its product range and expand internationally. To read the full article, click here.
Ostoform is proud to announce the publication of a clinical study in the highly respected Journal of Wound Ostomy & Continence Nursing. “A wonderful accolade and fantastic recognition”, stated Ostoform’s CEO, Kevin Kelleher. The study demonstrates a statistically significant improvement in skin condition for a cohort of participants who have an ileostomy. User feedback was …
